Previous 10 | Next 10 |
FORT MILL, SC / ACCESSWIRE / March 9, 2022 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has been notified of a new patent granted by the USPTO covering technology utilized in its VIVO product. The patent, number D980,420 S, entitled "Kit of Positioning Patches", was is...
New Study Confirms Advantages of Using VIVO for Pre-Procedure Ventricular Ablation Planning FORT MILL, SC / ACCESSWIRE / March 8, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has had new clinical data publish...
Catheter Precision's LockeT Successfully Used in Series of Patients FORT MILL, SC / ACCESSWIRE / March 6, 2023 / Ra Medical Systems, Inc. (RMED:NYSE/American) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has announced the first series of procedures using the ne...
Initial Shipments to Begin This Week FORT MILL, SC / ACCESSWIRE / February 14, 2023 / Ra Medical Systems, Inc. (NYSE/American:RMED) announced today that its wholly owned subsidiary, Catheter Precision, Inc., has launched its LockeT product into the marketplace, with initial shipments to its ...
FORT MILL, SC / ACCESSWIRE / February 10, 2023 / Ra Medical Systems (NYSE American:RMED) today announced the date of March 21, 2023 as the date of its special shareholder meeting. Shareholders of record as of February 3, 2023 are entitled to vote at the meeting. Among other items, shareholders ...
Catheter Precision Expands its VIVO™ Product into New Territories in the US FORT MILL, SC / ACCESSWIRE / February 1, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that addition...
Four abstracts with clinical data supporting use of Catheter Precision’s VIVO™ technology accepted for presentation at leading electrophysiology conference Ra Medical Systems, Inc. (NYSE American: RMED) (Ra Medical), a medical device and technology company focused on cardi...
Ra Medical Systems (NYSE American: RMED) announces a realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision, Inc. David Jenkins has joined the board as Executive Chairman and James Caruso has been named director. Martin Colombatto, Will M...
Ra Medical Systems ( NYSE: RMED ) completed its stock-for-stock merger with Catheter Precision and separately entered a equity financing agreement for up to $9.3M. Catheter Precision is focused on the cardiac electrophysiology market and its lead product is VIVO, an FDA-c...
Medtech Veteran and Catheter Precision CEO and Founder David Jenkins to Serve as Executive Chairman Enters Agreements to Raise up to $9.3 Million in Equity Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) announces the co...
News, Short Squeeze, Breakout and More Instantly...
Ra Medical Systems Inc. Company Name:
RMED Stock Symbol:
NYSE Market:
Ra Medical Systems Inc. Website:
Name change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023 FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced that its Board of Directors has approved cha...
First patent out of six applications on file for LockeT product FORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) today announced that it has received notification of allowance of the first patent to be issued for the company's LockeT product. Ent...
Catheter Precision's VIVO System Has Been Utilized in over 1,000 Procedures FORT MILL, SC / ACCESSWIRE / August 7, 2023 / Ra Medical Systems, Inc. (NYSE American:RMED) announced today that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricula...